MedPeer, Inc. (6095) AI Stock Analysis

• Market Cap: ¥15.32B
• Dividend Yield: 0.65%
• Average Volume (3M): 53.31K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.95
• Revenue Growth: -17.86%
• EPS Growth: 133.08%
• Country: JP
• Employees: 489
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.44
• Shares Outstanding: 22,010,330
• 10 Day Avg. Volume: 61,130
• 30 Day Avg. Volume: 53,310
• PEG Ratio: 0.06
• Price to Book (P/B): 1.29
• Price to Sales (P/S): 0.82
• P/FCF Ratio: 7.47
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 72 Outperform
• Price Target: ¥773.00 ▲(11.06% Upside)

The overall stock score of 72 reflects strong financial performance and attractive valuation, offset by neutral technical indicators. The company's solid revenue growth and efficient cost management are significant strengths. However, attention to cash flow management and bearish momentum indicators are areas of concern.

MedPeer, Inc. Business Overview & Revenue Model

Company Description

MedPeer, Inc. (6095) is a healthcare technology company that operates a peer-to-peer networking platform designed to connect healthcare professionals, including physicians and specialists. The company focuses on enhancing communication and collaboration among medical practitioners to improve patient outcomes and streamline the sharing of medical knowledge. MedPeer provides tools and resources that facilitate discussions on clinical cases, treatment options, and best practices, thereby fostering a community-driven approach to healthcare delivery.

How the Company Makes Money

MedPeer generates revenue primarily through subscription fees from healthcare organizations that utilize its platform for professional networking and collaboration. Additionally, the company may earn income from advertising partnerships with pharmaceutical companies and medical device manufacturers seeking to reach healthcare professionals. MedPeer may also explore data analytics services, leveraging aggregated insights from its network to provide valuable market intelligence to partners in the healthcare sector. Strategic partnerships with hospitals, clinics, and healthcare networks further enhance its revenue potential by expanding its user base and service offerings.

MedPeer, Inc. Financial Statement Overview

Summary

MedPeer, Inc. exhibits solid financial performance with strong revenue and profit growth, efficient cost management, and low leverage. However, cash flow management needs attention to support long-term growth and operational resilience.

Income Statement

MedPeer, Inc. demonstrates strong revenue growth with a notable increase from 2022 to TTM 2024. The gross profit margin is robust, indicating efficient cost management. While the net profit margin is healthy, the slight decline in EBIT margin suggests increasing operational expenses. Overall, the income statement reflects a solid financial performance with room for margin improvement.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio, indicating financial stability and low leverage risk. The equity ratio highlights a solid asset base supported by equity. Return on Equity (ROE) is commendable, showing efficient use of shareholder funds. However, the slight increase in total liabilities requires monitoring to ensure continued financial health.

Cash Flow

Cash flow analysis shows mixed results. The operating cash flow has significantly increased, demonstrating enhanced cash-generating capability. Free cash flow has grown, but the absence of recent data limits a complete trend analysis. The ratio of operating cash flow to net income is favorable, suggesting good cash conversion. Continued focus on sustaining cash flow growth is necessary.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	12.57B	14.95B	14.54B	8.45B	7.44B	5.31B
Gross Profit	5.75B	6.87B	6.87B	5.03B	4.85B	3.51B
EBITDA	1.55B	3.01B	1.87B	1.30B	1.98B	1.27B
Net Income	1.49B	1.48B	617.68M	812.39M	1.29B	725.97M
Balance Sheet
Total Assets	14.66B	15.55B	15.16B	9.35B	8.54B	7.13B
Cash, Cash Equivalents and Short-Term Investments	7.26B	7.28B	5.39B	6.14B	5.70B	4.70B
Total Debt	2.77B	3.16B	3.81B	179.12M	136.32M	202.90M
Total Liabilities	4.86B	6.10B	6.57B	1.49B	1.56B	1.55B
Stockholders Equity	9.80B	9.45B	8.30B	7.59B	6.71B	5.35B
Cash Flow
Free Cash Flow	0.00	1.63B	494.10M	691.01M	1.11B	758.87M
Operating Cash Flow	0.00	1.89B	600.07M	853.23M	1.36B	930.30M
Investing Cash Flow	0.00	1.27B	-5.01B	-422.88M	-345.39M	-469.23M
Financing Cash Flow	0.00	-1.27B	3.67B	7.08M	-15.44M	1.11B

MedPeer, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 696.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6095, the sentiment is Positive. The current price of 696 is above the 20-day moving average (MA) of 695.25, above the 50-day MA of 695.98, and above the 200-day MA of 600.34, indicating a bullish trend. The MACD of -0.57 indicates Negative momentum. The RSI at 48.93 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6095.

MedPeer, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	¥21.00B	18.32	―	1.93%	-6.29%	-22.25%
4320	74 Outperform	¥17.60B	16.72	―	2.19%	8.77%	1106.00%
6095	72 Outperform	¥15.32B	10.15	―	0.65%	-17.86%	133.08%
3939	67 Neutral	¥22.76B	22.38	―	1.57%	13.39%	12.00%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
4263	45 Neutral	¥15.38B	―	―	―	39.30%	32.06%
3902	43 Neutral	¥17.43B	-23.82	―	1.44%	-0.58%	-260.22%

MedPeer, Inc. Corporate Events

MedPeer, Inc. to Delist Shares Following Shareholder Approval

MedPeer, Inc. announced the approval of several resolutions at an extraordinary general meeting, including share consolidation and amendments to the articles of incorporation, which will lead to the delisting of its shares from the Tokyo Stock Exchange on October 17, 2025. This strategic move may impact the company’s market presence and shareholder value, as the shares will no longer be traded on the Prime Market.

The most recent analyst rating on (JP:6095) stock is a Buy with a Yen768.00 price target. To see the full list of analyst forecasts on MedPeer, Inc. stock, see the JP:6095 Stock Forecast page.

MedPeer, Inc. Announces Treasury Share Cancellation

MedPeer, Inc. has announced a resolution to cancel 311,521 of its treasury shares, which constitutes 1.42% of the total issued shares, pending approval at an extraordinary shareholders meeting. This move is part of a broader strategy involving share consolidation and amendments to the company’s articles of incorporation, potentially impacting the company’s capital structure and shareholder value.

The most recent analyst rating on (JP:6095) stock is a Hold with a Yen762.00 price target. To see the full list of analyst forecasts on MedPeer, Inc. stock, see the JP:6095 Stock Forecast page.

MedPeer, Inc. Announces Shareholder Meeting for Strategic Changes and Delisting

MedPeer, Inc. has announced an extraordinary general meeting of shareholders to discuss significant changes including share consolidation, amendments to the articles of incorporation, and a reduction in stated capital. These changes will lead to the company’s delisting from the Tokyo Stock Exchange, marking a significant shift in its market presence and operations. The move is part of a management buyout strategy, with the aim of privatizing the company and involving key stakeholders in its future direction.

The most recent analyst rating on (JP:6095) stock is a Hold with a Yen762.00 price target. To see the full list of analyst forecasts on MedPeer, Inc. stock, see the JP:6095 Stock Forecast page.

MedPeer, Inc. Announces Capital Reduction Plan

MedPeer, Inc. announced a capital reduction plan, approved by its Board of Directors, to be presented at the upcoming extraordinary general meeting of shareholders. The reduction aims to maintain financial health and ensure a flexible capital policy without affecting the number of shares or net assets per share.

MedPeer, Inc. Reports Decline in Nine-Month Financial Results

MedPeer, Inc. reported a decline in its consolidated financial results for the nine months ended June 30, 2025, with net sales dropping by 20.8% and operating profit decreasing by 27.6% compared to the previous year. Despite the financial challenges, the company maintained a stable equity-to-asset ratio and announced no revisions to its earnings forecasts, indicating a cautious yet steady approach to its financial strategy.

MedPeer Sets Record Date for Extraordinary Shareholders Meeting

MedPeer, Inc. has announced the setting of a record date for an upcoming Extraordinary General Meeting of Shareholders, scheduled between late September and early October 2025. This meeting follows a successful tender offer by NMT, Inc., although not all shares were acquired. The agenda includes proposals for share consolidation and amendments to the articles of incorporation, which could impact shareholder structure and governance.

MedPeer, Inc. Announces Change in Parent Company Following Successful Tender Offer

MedPeer, Inc. has announced the successful conclusion of a tender offer by NMT, Inc. for its common shares and stock acquisition rights, which began on May 15, 2025. As a result of the tender offer, NMT, Inc. will become the new parent company and largest major shareholder of MedPeer, Inc., with more than 50% of the voting rights, effective August 15, 2025. This change in ownership is expected to impact the company’s operations and market positioning.

MedPeer, Inc. Announces Amendments to MBO and Tender Offer Recommendations

MedPeer, Inc. has announced amendments to its previously issued notices regarding a Management Buyout (MBO) and a recommendation to tender shares. The company has resolved to support the tender offer initiated by NMT, Inc., which includes extending the tender offer period to provide shareholders with more time to decide. This decision is aimed at enhancing corporate value and ensuring fairness in the transaction, reflecting MedPeer’s commitment to its shareholders and corporate governance.

MedPeer Extends Tender Offer Period Amid Stable Share Price

MedPeer, Inc. announced an extension of the tender offer period by NMT, Inc. for its share certificates, now totaling 60 business days. The tender offer price remains unchanged at 700 yen per share, and no insider information affecting investor decisions has been reported. The settlement date is set for August 15, 2025, and the company has clarified that shares not tendered will be acquired by the Tender Offeror if the offer is successful.

MedPeer, Inc. Announces Extension of NMT, Inc.’s Tender Offer

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its shares. The tender offer, which began on May 15, 2025, has been extended to August 7, 2025, to provide shareholders more time to consider their participation. This extension aims to increase the likelihood of completing the tender offer, impacting MedPeer’s shareholder dynamics and potentially its market positioning.